Extrapulmonary Small Cell Neuroendocrine Carcinoma

• CLINICAL_TRIALS trial_result · 2024-11-13
  Clinical Trial Update: Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs [Phase 2]

  Phase 2 randomized trial evaluating topotecan with the ATR inhibitor M6620 (VX-970) in small cell lung cancer and extrapulmonary small cell …